Summit Therapeutics Inc. Number of Countries in which Entity Operates
Summit Therapeutics Inc. (SMMT) had Number of Countries in which Entity Operates of 2 country as of 2024-09-30, per its 10-Q filed 2024-10-30.
Financial Statements › Notes
us-gaap:NumberOfCountriesInWhichEntityOperates · last filed 2024-10-30
- 2024-09-30: Number of Countries in which Entity Operates 2.00 country.
- 2024-06-30: Number of Countries in which Entity Operates 2.00 country.
- 2024-03-31: Number of Countries in which Entity Operates 2.00 country.
- 2023-12-31: Number of Countries in which Entity Operates 2.00 country.
country
| Period end | Number of Countries in which Entity Operates |
|---|---|
| 2024-09-30 | 2.00 country 10-Q · filed 2024-10-30 |
| 2024-06-30 | 2.00 country 10-Q · filed 2024-08-06 |
| 2024-03-31 | 2.00 country 10-Q · filed 2024-05-01 |
| 2023-12-31 | 2.00 country 10-K · filed 2024-02-20 |
| 2023-09-30 | 2.00 country 10-Q · filed 2023-11-07 |
| 2023-06-30 | 2.00 country 10-Q · filed 2023-08-09 |
| 2023-03-31 | 2.00 country 10-Q · filed 2023-05-11 |
| 2022-12-31 | 2.00 country 10-K · filed 2023-03-09 |
| 2022-09-30 | 2.00 country 10-Q · filed 2022-11-09 |
| 2022-06-30 | 2.00 country 10-Q · filed 2022-08-11 |
| 2022-03-31 | 2.00 country 10-Q · filed 2022-05-11 |
| 2021-12-31 | 2.00 country 10-K/A · filed 2022-12-21 |
| 2020-12-31 | 2.00 country 10-K · filed 2021-03-31 |
segment
| Period end | Number of Countries in which Entity Operates |
|---|---|
| 2021-09-30 | 2.00 segment 10-Q · filed 2021-11-15 |
| 2021-06-30 | 2.00 segment 10-Q · filed 2021-08-12 |
| 2021-03-31 | 2.00 segment 10-Q · filed 2021-05-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |